Get started
Author

Marie‐Pierre Desrosiers

Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications
2009 · Murtuza Bharmal, Krista Payne, et al. · Health and Quality of Life Outcomes · 319
PDF
Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell–mediated innate resistance to cytomegalovirus infection
2005 · Marie-Pierre Desrosiers, Agnieszka Kielczewska, et al. · Nature Genetics · 149
Iron chelation therapy: Clinical effectiveness, economic burden and quality of life in patients with iron overload
2008 · Krista A. Payne, Diana Rofail, et al. · Advances in Therapy · 68
Clinical and economic burden of infused iron chelation therapy in the United States
2007 · Krista A. Payne, Marie‐Pierre Desrosiers, et al. · Transfusion · 45
Transfusions and patient burden in chemotherapy-induced anaemia in France
2014 · Patricia K. Corey-Lisle, Marie-Pierre Desrosiers, et al. · Therapeutic Advances in Medical Oncology · 19
Clinical characteristics and healthcare utilization of patients with multicentric Castleman disease
2014 · Corey Casper, Dana Y. Teltsch, et al. · British Journal of Haematology · 14
A retrospective study to evaluate the time burden associated with outpatient red blood transfusions indicated for anemia due to concomitantly administered chemotherapy in cancer patients
2012 · Sanatan Shreay, Marie-Pierre Desrosiers, et al. · Supportive Care in Cancer · 14
PDF
Early toxicity and health-related quality of life results of high-dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer
2018 · Marc Gaudet, Mathieu Pharand-Charbonneau, et al. · Brachytherapy · 9
Total Annual Costs of Infused Iron Chelation Therapy in the United States.
2006 · K.A. Payne, M.-P. Desrosiers, et al. · Blood · 7
Estimating the Total Cost of Infused Iron Chelation Therapy.
2005 · Marie-Pierre Desrosiers, Krista A. Payne, et al. · Blood · 3
Ferritin Levels, Compliance and Adverse Events Related to Infused Iron Chelation Therapy in a Cohort of Patients from Usual Care Setting in the United States.
2006 · K.A. Payne, M.-P. Desrosiers, et al. · Blood · 1
EP-2149 HDR brachytherapy as monotherapy for low and intermediate risk prostate cancer
2019 · M. Gaudet, M. Pharand-Charbonneau, et al. · Radiotherapy and Oncology
PDF
Early Toxicity and Health Related Quality of Life Results of HDR Brachytherapy as Monotherapy for Low/Intermediate Risk Prostate Cancer
2017 · Marc Gaudet, Mathieu Pharand-Charbonneau, et al. · Brachytherapy
Works count: 13
Citation count: 648
H-index: 8
I10-index: 7
Year
Topic
Type